
|Articles|August 1, 2002
Complexed PSA may be more specific than total PSA
Orlando FL-Measuring complexed PSA (cPSA) may provide improved specificity over total PSA (tPSA), according to the results of a multicenter trial. In their study, researchers from Innsbruck, Austria; Houston; New York; Cheyenne, WY; Stanford, CA; Baltimore; and Seattle compared the clinical performance of a cPSA test (Bayer Diagnostics, Tarrytown, NY) versus a standard tPSA test and PSA ratios (percent-free PSA and percent cPSA) as a first-line test for detecting prostate cancer.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Trial to compare 225Ac-PSMA-617 vs 177Lu-PSMA-617 for oligorecurrent prostate cancer
2
Farah Rahman, MD, on monitoring resident wellness using biofeedback
3
Pearls & Perspectives: Innovation and Evolving Pathways in Female Pelvic Medicine, with Raveen Syan, MD, FPMRS
4
Veda Giri, MD, on patient-reported outcomes with prostate cancer genetic testing
5






